Company Press

Arrow Dx is accepted into the 2022 Mass Challenge 2022 Early-Stage Cohort

2022 Mass Challenge Cohort Press Release

Arrow Dx joins more than 200 startups invited to participate in this year’s program.

BOSTON, MA (July 11, 2022) – Arrow Dx was selected to participate in the MassChallenge 2022 accelerator program. Arrow Dx was one of over 1,000 other startup applications for this year’s program.

“We look forward to all we have to gain throughout the program, and we’re excited to tap into the MassChallenge global network of mentors and partners,” said Edward Olano, Co-founder and CEO of Arrow Dx.

By participating in this accelerator, Arrow Dx will receive unrivaled access to a global network of partners, experts, and mentors; residency options; market access opportunities; and more to bolster our efforts to solve the biotechnology industry for zero cost and zero equity.

Arrow Dx is a Boston-based biotech startup working to single-handedly displace the liver biopsy from the fatty liver disease diagnostic process.  Arrow Dx condenses nanotechnology and machine learning into a handheld device that can detect critical biomarkers at the nanoscale––an inexpensive, ultra-sensitive, user-friendly blood test alternative to the liver biopsy. The beauty of our technology, however, is how seamlessly we bring together cutting-edge chemistry and AI-based software: our device’s enhanced sensitivity can, in fact, be calibrated to a variety of molecules for early-stage detection of a number of diseases in and beyond the liver space.

Arrow Dx’s technology is the key to unlocking fast, reliable, and flexible diagnostics for a wide variety of applications ranging from early-stage disease detection to environmental pollutant detection to quality control in the wine industry. Our mission is to develop new tools to help researchers and doctors detect chemical and biological entities in the fight against disease. Our goals at ArrowDx in the MassChallenge program are funding, more validation experiments, and commercialization as it relates to regulatory & reimbursement.

About MassChallenge

MassChallenge is the global network for innovators. Headquartered in the United States with eight locations worldwide, it is the non-profit’s mission to help bold entrepreneurs disrupt the status quo and create sustainable change. Since launching in 2009, MassChallenge has run programs in 18 countries, supported more than 3,000 startups from around the world, and awarded over $17M in equity-free cash and prizes. Learn more about MassChallenge at

Share on:

Want to get in touch?